Sign in
4

Changes in Ownership

Xilio Therapeutics, Inc. Filed Acc 0000899243-21-047829

10% owner bought 42,469 shares at an average $9.66 ($410,161)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bain Capital Life Sciences Investors, LLC 10% owner 2021-12-08 Purchase +13,458 $9.62 $129,474 2,776,402 I: show line 1 in the form
Bain Capital Life Sciences Investors, LLC 10% owner 2021-12-09 Purchase +4,011 $9.84 $39,485 2,780,413 I: show line 2 in the form
Bain Capital Life Sciences Investors, LLC 10% owner 2021-12-10 Purchase +21,812 $9.56 $208,564 2,802,225 I: show line 3 in the form
Bain Capital Life Sciences Investors, LLC 10% owner 2021-12-10 Purchase +3,188 $10.24 $32,638 2,805,413 I: show line 4 in the form
Open-market purchases · 42,469 sh · avg $9.66 · $410,161
Loading xslF345X03/doc4.xml…